Medical cannabis – the Canadian perspective

References

• ZuardiAWHistory of cannabis as a medicine: a reviewRev Bras Psiquiatr200628215315716810401
   PubMed Web of Science ®Google Scholar
• TurcotteDLe DorzeJ-AEsfahaniFFrostEGomoriANamakaMExamining the roles of cannabinoids in pain and other therapeutic indications: a reviewExpert Opin Pharmacother2010111173120001426
   PubMed Web of Science ®Google Scholar
• HirstRALambertDGNotcuttWGPharmacology and potential therapeutic uses of cannabisBr J Anaesth199881177849771275
   PubMed Web of Science ®Google Scholar
• AldrichMHistory of therapeutic cannabisMathreMLCannabis in Medical Practice: A Legal, Historical, and Pharmacological Overview of the Therapeutic Use of MarijuanaJefferson, NCMcFarland & Co.19973555
   Google Scholar
• BoychukDGGoddardGMauroGOrellanaMFThe effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic reviewJ Oral Facial Pain Headache201529171425635955
   PubMed Web of Science ®Google Scholar
• TramèrMRCarrollDCampbellFAReynoldsDJMooreRAMcQuayHJCannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic reviewBMJ20013237303162111440936
   PubMed Web of Science ®Google Scholar
• TrouttWDDiDonatoMDMedical cannabis in Arizona: patient characteristics, perceptions, and impressions of medical cannabis legalizationJ Psychoactive Drugs201547425926626317379
   PubMed Web of Science ®Google Scholar
• Bonn-MillerMOBodenMTBucossiMMBabsonKASelf-reported cannabis use characteristics, patterns and helpfulness among medical cannabis usersAm J Drug Alcohol Abuse2014401233024205805
   PubMed Web of Science ®Google Scholar
• IlgenMABohnertKKleinbergFCharacteristics of adults seeking medical marijuana certificationDrug Alcohol Depend2013132365465923683791
   PubMed Web of Science ®Google Scholar
• WalshZCallawayRBelle-IsleLCannabis for therapeutic purposes: patient characteristics, access, and reasons for useInt J Drug Policy201324651151624095000
   PubMed Web of Science ®Google Scholar
• Di FortiMMorrisonPDButtAMurrayRMCannabis use and psychiatric and cognitive disorders: the chicken or the egg?Curr Opin Psychiatry200720322823417415074
   PubMed Web of Science ®Google Scholar
• SchauerGLKingBABunnellREPromoffGMcAfeeTAToking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014Am J Prev Med20165011826277652
   PubMed Web of Science ®Google Scholar
• Belle-IsleLHathawayABarriers to access to medical cannabis for Canadians living with HIV/AIDSAIDS Care200719450050617453590
   PubMed Web of Science ®Google Scholar
• Canadian Centre on Substance AbuseCanadian addiction survey 2004: microdata eguideOttawa, ONCanadian Centre on Substance Abuse Available from: http://www.ccsa.ca/Resource%20Library/ccsa-004028-2005.pdfAccessed August 20, 2015
   Google Scholar
• EbertTZolotovYEliavSGinzburgOShapiraIMagneziRAssessment off Israeli physicians’ knowledge, experience and attitudes towards medical cannabis: a pilot studyIsr Med Assoc J201517743744126357721
   PubMed Web of Science ®Google Scholar
• FrankBSerpellMGHughesJMatthewsJNKapurDComparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind studyBMJ2008336763719920118182416
   PubMed Web of Science ®Google Scholar
• GlassRMUhlenhuthEHHartelFWThe effects of nabilone, a synthetic cannabinoid, on anxious human volunteers [proceedings]Psychopharmacol Bull19791528890373011
   PubMedGoogle Scholar
• LembergerLRubinAWolenRPharmacokinetics, metabolism and drug-abuse potential of nabiloneCancer Treat Rev19829Suppl B17236299550
   PubMed Web of Science ®Google Scholar
• McGilverayIJPharmacokinetics of cannabinoidsPain Res Manag200510Suppl A15A22A15782243
   PubMedGoogle Scholar
• PertweeRGCannabinoid receptors and painProg Neurobiol200163556961111164622
   PubMed Web of Science ®Google Scholar
• Ben-ShabatSHanušLOKatzavianGGallilyRNew cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activityJ Med Chem20064931113111716451075
   PubMed Web of Science ®Google Scholar
• MaioneSPiscitelliFGattaLNon-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of actionBr J Pharmacol2011162358459620942863
   PubMed Web of Science ®Google Scholar
• CostaBTrovatoAEComelliFGiagnoniGColleoniMThe non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic painEur J Pharmacol20075561–3758317157290
   PubMed Web of Science ®Google Scholar
• NiesinkRJvan LaarMWDoes cannabidiol protect against adverse psychological effects of THC?Front Psychiatry2013164130
   Google Scholar
• IsegerTABossongMGA systematic review of the antipsychotic properties of cannabidiol in humansSchizophr Res20151621–315316125667194
   PubMed Web of Science ®Google Scholar
• De MeijerEPMBagattaMCarboniAThe inheritance of chemical phenotype in Cannabis sativa LGenetics2003163133534612586720
   PubMed Web of Science ®Google Scholar
• RussoEGuyGWA tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiolMed Hypotheses200666223424616209908
   PubMed Web of Science ®Google Scholar
• IzzoAABorrelliFCapassoRDi MarzoVMechoulamRNon-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herbTrends Pharmacol Sci200930151552719729208
   PubMed Web of Science ®Google Scholar
• FrideEMechoulamRPharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituentEur J Pharmacol199323123133148384116
   PubMed Web of Science ®Google Scholar
• TsouKBrownSSañudo-PeñaMCMackieKWalkerJMImmunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous systemNeuroscience19988323934119460749
   PubMed Web of Science ®Google Scholar
• WalkerJMHuangSMStrangmanNMTsouKSañudo-PeñaMCPain modulation by release of the endogenous cannabinoid anandamideProc Natl Acad Sci U S A19999621121981220310518599
   PubMed Web of Science ®Google Scholar
• Wilson-PoeARMorganMMAicherSAHegartyDMDistribution of CB1 cannabinoid receptors and their relationship with mu-opioid receptors in the rat periaqueductal grayNeuroscience201221319120022521830
   PubMed Web of Science ®Google Scholar
• HashimotodaniYOhno-ShosakuTKanoMEndocannabinoids and synaptic function in the CNSNeuroscientist200713212713717404373
   PubMed Web of Science ®Google Scholar
• SolteszIAlgerBEKanoMWeeding out bad waves: towards selective cannabinoid circuit control in epilepsyNat Rev Neurosci201516526427725891509
   PubMed Web of Science ®Google Scholar
• RichardsonJDAanonsenLHargreavesKMSR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated miceEur J Pharmacol19973192–3R3R49042616
   PubMed Web of Science ®Google Scholar
• NicholsonANTurnerCStoneBMRobsonPJEffect of delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adultsJ Clin Psychopharmacol200424330531315118485
   PubMed Web of Science ®Google Scholar
• KarniolIGShirakawaIKasinskiNPfefermanACarliniEACannabidiol interferes with the effects of delta 9-tetrahydrocannabinol in manEur J Pharmacol19742811721774609777
   PubMed Web of Science ®Google Scholar
• ZuardiAWShirakawaIFinkelfarbEKarniolIGAction of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjectsPsychopharmacology (Berl)19827632452506285406
   PubMed Web of Science ®Google Scholar
• BisognoTHanusLDe PetrocellisLMolecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamideBr J Pharmacol2001134484585211606325
   PubMed Web of Science ®Google Scholar
• Health Canada Controlled Substances Tobacco DirectorateInformation for health care professionals: cannabis (marihuana, marijuana) and the cannabinoidsOttawa, ONHealth Canada, Controlled Substances and Tobacco Directorate2013 Available from: http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.phpAccessed August 3, 2015
   Google Scholar
• AbramsDIJayCAShadeSBCannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trialNeurology200768751552117296917
   PubMed Web of Science ®Google Scholar
• EllisRJToperoffWVaidaFSmoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trialNeuropsychopharmacology200934367268018688212
   PubMed Web of Science ®Google Scholar
• WareMAWangTShapiroSSmoked cannabis for chronic neuropathic pain: a randomized controlled trialCMAJ201018214E694E70120805210
   PubMed Web of Science ®Google Scholar
• WilseyBMarcotteTTsodikovAA randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic painJ Pain20089650652118403272
   PubMed Web of Science ®Google Scholar
• WilseyBMarcotteTDeutschRLow-dose vaporized cannabis significantly improves neuropathic painJ Pain201314213614823237736
   PubMed Web of Science ®Google Scholar
• Corey-BloomJWolfsonTGamstASmoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trialCMAJ2012184101143115022586334
   PubMed Web of Science ®Google Scholar
• AndreaeMHCarterGMShaparinNInhaled cannabis for chronic neuropathic pain: a meta-analysis of individual patient dataJ Pain201516121221123226362106
   PubMed Web of Science ®Google Scholar
• WiffenPJDerrySMooreRAAntiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviewsCochrane Database Syst Rev201311CD01056724217986
   PubMed Web of Science ®Google Scholar
• BirseFDerrySMooreRAPhenytoin for neuropathic pain and fibromyalgia in adultsCochrane Database Syst Rev20125CD00948522592741
   PubMed Web of Science ®Google Scholar
• ChaparroLEWiffenPJMooreRAGilronICombination pharmacotherapy for the treatment of neuropathic pain in adultsCochrane Database Syst Rev20127CD00894322786518
   PubMed Web of Science ®Google Scholar
• CorriganRDerrySWiffenPJMooreRAClonazepam for neuropathic pain and fibromyalgia in adultsCochrane Database Syst Rev20125CD00948622592742
   PubMed Web of Science ®Google Scholar
• Canadian Cancer SocietyMedical marijuana and cannabinoids2015 Available from: http://www.cancer.ca/en/cancer-information/diagnosis-and-treatment/complementary-therapies/medical-marijuana-and-cannabinoids/?region=onAccessed August 3, 2015
   Google Scholar
• HuestisMAHuman cannabinoid pharmacokineticsChem Biodivers2007481770180417712819
   PubMed Web of Science ®Google Scholar
• AgurellSHalldinMLindgrenJEPharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on manPharmacol Rev198638121433012605
   PubMed Web of Science ®Google Scholar
• ZuurmanLIppelAEMoinEvan GervenJMABiomarkers for the effects of cannabis and THC in healthy volunteersBr J Clin Pharmacol200967152119133057
   PubMed Web of Science ®Google Scholar
• CarterGTWeydtPKyashna-TochaMAbramsDIMedicinal cannabis: rational guidelines for dosingIDrugs20047546447015154108
   PubMed Web of Science ®Google Scholar
• HartCLIlanABGevinsANeurophysiological and cognitive effects of smoked marijuana in frequent usersPharmacol Biochem Behav201096333334120600251
   PubMed Web of Science ®Google Scholar
• WalshDNelsonKAMahmoudFAEstablished and potential therapeutic applications of cannabinoids in oncologySupport Care Cancer200311313714312618922
   PubMed Web of Science ®Google Scholar
• ConeEJJohnsonREPaulBDMellLDMitchellJMarijuana-laced brownies: behavioral effects, physiologic effects, and urinalysis in humans following ingestionJ Anal Toxicol19881241691753184885
   PubMed Web of Science ®Google Scholar
• The Netherlands Ministry of Health Welfare and SportsMedicinal Cannabis, Information for Health Care ProfessionalsAmsterdam, the NetherlandsThe Netherlands Ministry of Health Welfare and Sports2008
   Google Scholar
• LiX-QAnderssonTBAhlströmMWeidolfLComparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome p450 activitiesDrug Metab Dispos200432882182715258107
   PubMed Web of Science ®Google Scholar
• SpinaESantoroVD’ArrigoCClinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an updateClin Ther20083071206122718691982
   PubMed Web of Science ®Google Scholar
• KarolyPRuehlmanLSOkunMAPsychosocial and demographic correlates of employment vs disability status in a national community sample of adults with chronic pain: toward a psychology of pain presenteeismPain Med201314111698170724010682
   PubMed Web of Science ®Google Scholar
• The Arthritis SocietyMedical cannabis: a guide to access2015 Available from: http://arthritis.ca/getmedia/99682fb5-3992-4924-895a-d5f03d16f151/Medical-Cannabis-2015-a-Guide-to-Access.pdfAccessed August 10, 2015
   Google Scholar
• GuptaSWhy I changed my mind on weed2013 Available from: http://frogbuddha.com/?p=234Accessed July 30, 2015
   Google Scholar
• Belle-IsleLWalshZCallawayRBarriers to access for Canadians who use cannabis for therapeutic purposesInt J Drug Policy201425469169924947993
   PubMed Web of Science ®Google Scholar
• Lopez-QuinteroCPérez de los CobosJHasinDSProbability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)Drug Alcohol Depend20111151–212013021145178
   PubMed Web of Science ®Google Scholar
• HoodSDNormanAHinceDAMelicharJKHulseGKBenzodiazepine dependence and its treatment with low dose flumazenilBr J Clin Pharmacol201477228529423126253
   PubMed Web of Science ®Google Scholar
• Health CanadaAbout the Marihuana Medical Access Program2014 Available from: http://www.hc-sc.gc.ca/dhp-mps/marihuana/about-apropos/index-eng.phpAccessed August 5, 2015
   Google Scholar
• Government of CanadaJustice Laws Website. Marihuana for Medical Purposes Regulations2015 Available from: http://www.laws-lois.justice.gc.ca/eng/regulations/SOR-2013-119Accessed August 25, 2015
   Google Scholar
• Health CanadaAuthorized licensed producers under the Marihuana for Medical Purposes Regulations2015 Available from: http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/list-eng.phpAccessed August 5, 2015
   Google Scholar
• Government of CanadaJustice Laws Website. Marihuana for Medical Purposes Regulations2015 Available from: http://www.laws-lois.justice.gc.ca/eng/regulations/SOR-2013-119/page-6.htmlAccessed August 10, 2015
   Google Scholar
• HazekampAHeerdinkERThe prevalence and incidence of medicinal cannabis on prescription in the NetherlandsEur J Clin Pharmacol20136981575158023588562
   PubMed Web of Science ®Google Scholar
• MoirDRickertWSLevasseurGA comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditionsChem Res Toxicol200821249450218062674
   PubMed Web of Science ®Google Scholar
• PomahacovaBVan der KooyFVerpoorteRCannabis smoke condensate III: the cannabinoid content of vaporised Cannabis sativaInhal Toxicol200921131108111219852551
   PubMed Web of Science ®Google Scholar
• ScavoneJMGreenblattDJFriedmanHShaderRIEnhanced bioavailability of triazolam following sublingual versus oral administrationJ Clin Pharmacol19862632082103958225
   PubMed Web of Science ®Google Scholar
• KoGWineWTumarkinECase series of fibromyalgia patients with neuropathic pain improved with the sublingual cannabinoid SativexEur J Pain200711S1145146
   Google Scholar
• KimS-WDoddSBerkLImpact of cannabis use on long-term remission in bipolar I and schizoaffective disorderPsychiatry Investig2015123349355
   Web of Science ®Google Scholar
• LeiteRTPNogueiraSde Odo NascimentoJPRThe use of cannabis as a predictor of early onset of bipolar disorder and suicide attemptsNeural Plast2015201543412726097750
   PubMed Web of Science ®Google Scholar
• LarramendiCHLópez-MatasMÁFerrerAPrevalence of sensitization to Cannabis sativa. Lipid-transfer and thaumatin-like proteins are relevant allergensInt Arch Allergy Immunol2013162211512223921252
   PubMed Web of Science ®Google Scholar
• OcampoTLRansTSCannabis sativa: the unconventional “weed” allergenAnn Allergy Asthma Immunol2015114318719225744904
   PubMed Web of Science ®Google Scholar
• GuptaBNMehrotraNKClerkSHImmunotherapy in hemp workers having respiratory complaintsIndian J Med Sci198034472817439959
   PubMedGoogle Scholar
• KumarRGuptaNA case of bronchial asthma and allergic rhinitis exacerbated during Cannabis pollination and subsequently controlled by subcutaneous immunotherapyIndian J Allergy Asthma Immunol2013272143
   Google Scholar
• WangTColletJPShapiroSWareMAAdverse effects of medical cannabinoids: a systematic reviewCMAJ2008178131669167818559804
   PubMed Web of Science ®Google Scholar
• Health CanadaConsumer information – cannabis (marihuana, marijuana)2015 Available from: http://www.hc-sc.gc.ca/dhp-mps/marihuana/info/cons-eng.phpAccessed August 3, 2015
   Google Scholar
• DegenhardtLHallWDThe adverse effects of cannabinoids: implications for use of medical marijuanaCMAJ2008178131685168618559807
   PubMed Web of Science ®Google Scholar
• BelendiukKABaldiniLLBonn-MillerMONarrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disordersAddict Sci Clin Pract2015101025896576
   PubMed Web of Science ®Google Scholar